Diallebo
About:
Diallebo is a biotech company that focuses on R&D of laboratory testing products for autoimmune diseases and neurological diseases.
Top Investors: Grand Yangtze Capital, Shulan Junjie Capital, Smart Venture Capital, Zhangjiagang Jinmao Venture Capital, Zhangjiagang Talent No. 1 Fund
Description:
Diallebo is a biotech company that focuses on R&D, manufacturing & sales of laboratory testing products for autoimmune diseases and neurological diseases.
Total Funding Amount:
100M CNY
Headquarters Location:
Zhangjiagang, Jiangsu, China
Founded Date:
2016-01-01
Founders:
Number of Employees:
Last Funding Date:
2023-09-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai